Vertex Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $15.414; its P/E ratio is 27.81; Vertex Pharmaceuticals is scheduled to report earnings on August 1, 2024, and the estimated EPS forecast is $4.17. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23
Income Statement	-
Total Revenue	$ 2.69B	$ 2.52B	$ 2.48B	$ 2.49B	$ 2.37B
Gross Profit	$ 2.35B	$ 2.15B	$ 2.16B	$ 2.18B	$ 2.11B
EBIT	$ 1.29B	$ 1.17B	$ 1.19B	$ 1.17B	$ 902.90M
EBITDA	$ 1.34B	$ 1.23B	-	$ 1.21B	$ 941.70M
Net Income Common Stockholders	$ 1.10B	$ 968.80M	$ 1.04B	$ 915.70M	$ 699.80M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 10.17B	$ 11.22B	$ 11.93B	$ 11.24B	$ 10.41B
Total Assets	$ 23.92B	$ 22.73B	$ 21.73B	$ 20.35B	$ 18.97B
Total Debt	$ 721.30M	$ 724.70M	$ 744.70M	$ 767.60M	$ 789.20M
Net Debt	$ -9.45B	$ -10.49B	$ -11.18B	$ -10.47B	$ -9.62B
Total Liabilities	$ 5.37B	$ 5.15B	$ 5.21B	$ 4.88B	$ 4.54B
Stockholders Equity	$ 18.55B	$ 17.58B	$ 16.51B	$ 15.47B	$ 14.43B
Cash Flow	-
Free Cash Flow	$ 1.24B	$ 118.50M	-	$ 1.08B	$ 859.70M
Operating Cash Flow	$ 1.31B	$ 234.60M	$ 1.27B	$ 1.14B	$ 901.80M
Investing Cash Flow	$ -2.14B	$ -886.50M	$ -115.20M	$ -304.50M	$ -1.84B
Financing Cash Flow	$ -357.50M	$ -119.80M	$ -165.00M	$ 17.30M	$ -294.70M

Currency in USD

Vertex Pharmaceuticals Earnings and Revenue History

Income Statement >

Vertex Pharmaceuticals Debt to Assets

Balance Sheet >

Vertex Pharmaceuticals Cash Flow

Cash Flow >

Vertex Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing